Стандарти медичної допомоги при дiабетi Американської асоцiацiї дiабетологiв, 2019 (Вибранi положення)
DOI:
https://doi.org/10.2337/dc19-S003Анотація
Diabetes Care 2019;42(Suppl. 1):S29-S33 | https://doi.org/10.2337/dc19-S003
«Стандарти медичної допомоги при діабеті» Американської асоціації діабетологів (АDA) містять рекомендації з чинної клінічної практики та призначені для забезпечення компонентів лікування діабету, загальних цілей лікування та нормативних настанов, а також інструментів для оцінки якості медичної допомоги. Члени Комітету професійної практичної діяльності АDA, Міждисциплінарний експертний комітет, несуть відповідальність за щорічне оновлення стандартів медичної допомоги, або частіше, якщо оновлення обґрунтовано. Для детального опису стандартів АDA, вкладень та звітів, а також системи класифікації даних для рекомендацій АDA щодо клінічної практики, зверніться, будь ласка, до вступної частини Стандартів медичної допомоги. Читачі, які бажають коментувати Стандарти медичної допомоги, можуть зробити це за адресою professional.diabetes.org/SOC.
Посилання
Diabetes Prevention Program Research Group. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin / Knowler W. C., Barrett-Connor E., Fowler S. E. [et al.] // N. Engl. J. Med. – 2002. – No. 346. – Р. 393–403.
Finnish Diabetes Prevention Study Group. Sustained reduction in the incidence of type 2 diabetes by lifestyle intervention: follow-up of the Finnish Diabetes Prevention Study / Lindstrom J., Ilanne-Parikka P., Peltonen M. [et al.] // Lancet. – 2006. – No. 368. – Р. 1673–1679.
Cardiovascular mortality, all-cause mortality, and diabetes incidence after lifestyle intervention for people with impaired glucose tolerance in the Da Qing Diabetes Prevention Study: a 23-year follow-up study / Li G., Zhang P., Wang J., [et al.] // Lancet Diabetes Endocrinol. – 2014. – No. 2. – Р. 474–480.
Diabetes Prevention Program Research Group. 10-year follow-up of diabetes incidence and weight loss in the Diabetes Prevention Program Outcomes Study / Knowler W. C., Fowler S. E., Hamman R. F. [et al.] // Lancet. – 2009. – No. 374. – Р. 1677–1686.
Long-term effects of lifestyle intervention or metformin on diabetes development and microvascular complications over 15-year follow-up: the Diabetes Prevention Program Outcomes Study / Nathan D. M., Barrett-Connor E., Crandall J. P. [et al.] // Lancet Diabetes Endocrinol. – 2015. – No. 3. – Р. 866–875.
Diabetes Prevention Program (DPP) Research Group. The Diabetes Prevention Program (DPP): description of lifestyle intervention // Diabetes Care. – 2002. – No. 25 – Р. 2165–2171.
Effect of weight loss with lifestyle intervention on risk of diabetes / Hamman R. F., Wing R. R., Edelstein S. L. [et al.] // Diabetes Care. – 2006. – No. 29. – Р. 2102– 2107.
PREDIMED Study Investigators. Reduction in the incidence of type 2 diabetes with the Mediterranean diet: results of the PREDIMED-Reus nutrition intervention randomized trial / Salas-Salvado J., Bullo M., Babio N. [et al.] // Diabetes Care. – 2011. – No. 34. – Р. 14–19.
Protective effects of the Mediterranean diet on type 2 diabetes and metabolic syndrome / Salas-Salvado J., Guasch-Ferre M., Lee C-H. [et al.] // J. Nutr. – 2016. – No. 146. – Р. 920S–927S.
Effects on health outcomes of a Mediterranean diet with no restriction on fat intake: a systematic review and meta-analysis / Bloomfield H. E., Koeller E., Greer N. [et al.] // Ann. Intern. Med. – 2016. – No. 165. – Р. 491–500.
PREDIMED Study Investigators. Primary prevention of cardiovascular disease with a Mediterranean diet supplemented with extra-virgin olive oil or nuts / Estruch R., Ros E., Salas-Salvado J. [et al.] // N. Engl. J. Med. – 2018. – No. 378. – Р. e34.
Longterm low-carbohydrate diets and type 2 diabetes risk: a systematic review and meta-analysis of observational studies / Noto H., Goto A., Tsujimoto T., Noda M. // J. Gen. Fam. Med. – 2016. – No. 17. – Р. 60–70.
Prevention and management of type 2 diabetes: dietary components and nutritional strategies / Ley S. H., Hamdy O., Mohan V., Hu F. B. // Lancet. – 2014. – No. 383. – Р. 1999–2007.
A priori-defined diet quality indexes and risk of type 2 diabetes: the Multiethnic Cohort / Jacobs S., Harmon B. E., Boushey C. J. [et al.] // Diabetologia. – 2015. – No. 58. – Р. 98–112.
Alternative dietary indices both strongly predict risk of chronic disease / Chiuve S. E., Fung T. T., Rimm E. B. [et al.] // J. Nutr. – 2012. – No. 142. – Р. 1009–1018.
Consumption of nuts and legumes and risk of incident ischemic heart disease, stroke, and diabetes: a systematic review and meta-analysis / Afshin A., Micha R., Khatibzadeh S., Mozaffarian D. // Am. J. Clin. Nutr. – 2014. – No. 100. – Р. 278–288.
Intake of fruit, berries, and vegetables and risk of type 2 diabetes in Finnish men: the Kuopio Ischaemic Heart Disease Risk Factor Study / Mursu J., Virtanen J. K., Tuomainen T-P. [et al.] // Am. J. Clin. Nutr. – 2014. – No. 99. – Р. 328–333.
Dairy consumption and risk of type 2 diabetes: 3 cohorts of US adults and an updated meta-analysis / Chen M., Sun Q., Giovannucci E. [et al.] // BMC Med. – 2014. – No. 12. – Р. 215.
Prospective Urban Rural Epidemiology (PURE) study investigators. Association of dairy intake with cardiovascular disease and mortality in 21 countries from five continents (PURE): a prospective cohort study / Dehghan M., Mente A., Rangarajan S. [et al.] // Lancet. 11 September 2018 [Epub ahead of print]. DOI: 10.1016/ S0140-6736(18)31812-9.
Mozaffarian D. Dietary and policy priorities for cardiovascular disease, diabetes, and obesity: a comprehensive review / Mozaffarian D. // Circulation. – 2016. – No. 133. – Р. 187–225.
The effect ofmedical nutritiontherapy by a registered dietitian nutritionist in patients with prediabetes participating in a randomized controlled clinical research trial / Parker A. R., Byham-Gray L., Denmark R., Winkle P. J. // J. Acad. Nutr. Diet. – 2014. – No. 114. – Р. 1739–1748.
Exercise and insulin resistance in youth: a metaanalysis / Fedewa M. V., Gist N. H., Evans E. M., Dishman R. K. // Pediatrics. – 2014. – 133. – Р. e163–e174.
Davis C.L., Pollock N.K., Waller J.L. [et al.] Exercise dose and diabetes risk in overweight and obese children: a randomized controlled trial / // JAMA. – 2012. – No. 308. – Р. 1103–1112.
Effects of aerobic training, resistance training, or both on percentage body fat and cardiome-tabolic risk markers in obese adolescents: the healthy eating aerobic and resistance training in youth randomized clinical trial / Sigal R. J., Alberga A. S., Goldfield G. S. [et al.] // JAMA Pediatr. – 2014. – No. 168. – Р. 1006–1014.
Alternating bouts of sitting and standing attenuate postprandial glucose responses / Thorp A. A., Kingwell B. A., Sethi P. [et al.] // Med. Sci. Sports. Exerc. – 2014. – No. 46. – Р. 2053–2061.
Breaks in sedentary time: beneficial associations with metabolic risk /
Healy G. N., Dunstan D. W., Salmon J. [et al.] // Diabetes Care. – 2008. – No. 31. – Р. 661–666.
Physical activity interventions in pregnancy and risk of gestational diabetes mellitus: a systematic review and meta-analysis / Russo L. M., Nobles C., Ertel K. A. [et al.] // Obstet Gynecol. – 2015. – No. 125. – Р. 576–582.
A review of technology-assisted interventions for diabetes prevention / Grock S., Ku J-H., Kim J., Moin T. // Curr. Diab. Rep. – 2017. – No. 17. – Р. 107.
Sepah S. C. Translating the Diabetes Prevention Program into an online social network: validation against CDC standards / Sepah S. C., Jiang L., Peters A. L. // Diabetes Educ. – 2014. – No. 40. – Р. 435–443.
The effect of technology-mediated diabetes prevention interventions on weight: a meta-analysis / Bian R. R., Piatt G. A., Sen A. [et al.] // J Med Internet Res. – 2017. – No. 19. – Р. e76.
Sepah S. C. Long-term outcomes of a Web-based diabetes prevention program: 2-year results of a single-arm longitudinal study / Sepah S. C., Jiang L., Peters A. L. // J. Med. Internet. Res. – 2015. – No. 17. – Р. e92.
Diabetes Prevention Program Research Group. The cost-effectiveness of lifestyle modification or metformin in preventing type 2 diabetes in adults with impaired glucose tolerance / Herman W. H., Hoerger T. J., Brandle M. [et al.] // Ann. Intern. Med. – 2005. – No. 142. – Р. 323–332.
Clinical and economic impact of a digital, remotely-delivered intensive behavioral counseling program on Medicare beneficiaries at risk for diabetes and cardiovascular disease / Chen F., Su W., Becker S. H. [et al.] // PLoS One. – 2016. – No. 11. – Р. e0163627.
Diabetes Prevention Program Research Group. The 10-year cost-effectiveness of lifestyle intervention or metformin for diabetes prevention: an intent-to-treat analysis of the DPP/ DPPOS / // Diabetes Care. – 2012. – No. 35. – Р. 723–730.
Translating the Diabetes Prevention Program into the community. The DEPLOYPilotStudy / Ackermann R. T., Finch E. A., Brizendine E. [et al.] // Am. J. PrevMed. – 2008. – No. 35. – Р. 357–363.
Combined diet and physical activity promotion programs to prevent type 2 diabetes among persons at increased risk: a systematic review for the Community Preventive Services Task Force / Balk E. M., Earley A., Raman G. [et al.] // Ann. Intern. Med. – 2015. – No. 163. – Р. 437–451.
Economicevaluation of combined diet and physical activity promotion programs to prevent type 2 diabetes among persons at increased risk: a systematic review for the Community Preventive Services Task Force / Li R., Qu S., Zhang P. [et al.] // Ann. Intern. Med. – 2015. – No. 163. – Р. 452–460.
The Community Guide. Diabetes prevention: interventions engaging community health workers [Internet], 2016. Available from https:// www.thecommunityguide.org/findings/diabetes-prevention-interventions-engaging-community-health-workers. Accessed 25 September 2018.
A national effort to prevent type 2 diabetes: participant-level evaluation of CDC’s National Diabetes Prevention Program / Ely E. K., Gruss S. M., Luman E. T. [et al.] // Diabetes Care. – 2017. – No. 40. – Р. 1331–1341.
Smoking, smoking cessation, and risk for type 2 diabetes mellitus: a cohort study / Yeh H-C., Duncan B. B., Schmidt M. I. [et al.] // Ann. Intern. Med. – 2010. – No. 152. – Р. 10–17.
Smoking cessation increases short-term risk of type 2 diabetes irrespective of weight gain: the Japan Public Health Center-Based Prospective Study [published correction appears in PLoS One 2013; 8:10.1371/annotation/23aa7c42-9a4d-42a7-8f50-9d0ac4b85396] / Oba S., Noda M., Waki K. [et al.] // PLoS One. – 2012. – No. 7. – Р. e17061.
Smoking cessation, weight change, type 2 diabetes, and mortality / Hu Y., Zong G., Liu G. [et al.] // N. Engl. J. Med. – 2018. – No. 379. – Р. 623–632.
STOP-NIDDM Trail Research Group. Acarbose for prevention of type 2 diabetes mellitus: the STOP-NIDDM randomised trial / Chiasson J-L., Josse R.G., Gomis R. [et al.] // Lancet. – 2002. – No. 359. – Р. 2072–2077.
XENical in the prevention of Diabetes in Obese Subjects (XENDOS) study: a randomized study of orlistat as an adjunct to lifestyle changes for the prevention of type 2 diabetes in obese patients / Torgerson J. S., Hauptman J., Boldrin M. N., Sjostrom L. // Diabetes Care. – 2004. – No. 27. – Р. 155-161.
SCALE Obesity Prediabetes NN8022-1839 Study Group. 3 years of liraglutide versus placebo for type 2 diabetes risk reduction and weight management in individuals with prediabetes: a randomised, double-blind trial / le Roux C.W., Astrup A., Fujioka K. [et al.] // Lancet. – 2017. – No. 389. – Р. 1399–1409.
DREAM (Diabetes REduction Assessment with ramipril and rosiglitazone Medication) Trial Investigators. Effect of rosiglitazone on the frequency of diabetes in patients with impaired glucose tolerance or impaired fasting glucose: a randomised controlled trial / Gerstein H.C., Yusuf S., Bosch J. [et al.] // Lancet. – 2006. – No. 368. – Р. 1096–1105.
ACT NOW Study. Pioglitazone for diabetes prevention in impaired glucose tolerance / DeFronzo R. A., Tripathy D., Schwenke D. C. [et al.] // N. Engl. J. Med. – 2011. – 364. – Р. 1104–1115.
Diabetes Prevention Program Research Group. Long-term safety, tolerability, and weight loss associated with metformin in the Diabetes Prevention Program Outcomes Study // Diabetes Care. – 2012. – No. 35. – Р. 731–737.
Prevention of type 2 diabetes in subjects with prediabetes and metabolic syndrome treated with phentermine and topiramate extended release / Garvey W. T., Ryan D. H., Henry R. [et al.] // Diabetes Care. – 2014. – No. 37. – Р. 912–921.
Review of metformin use for type 2 diabetes prevention / Moin T., Schmittdiel J. A., Flory J. H. [et al.] // Am. J. Prev. Med. – 2018. – No. 55. – Р. 565–574.
Diabetes Prevention Program Research Group. Prevention of diabetes in women with a history of gestational diabetes: effects of metformin and lifestyle interventions / Ratner R. E., Christophi C. A., Metzger B. E. [et al.] // J. Clin. Endocrino. Metab. – 2008. – No. 93. – Р. 4774–4779.
Diabetes Prevention Program Research Group. The effect of lifestyle intervention and metformin on preventing or delaying diabetes among women with and without gestational diabetes: the Diabetes Prevention Program Outcomes Study 10-year follow-up / Aroda V. R., Christophi C. A., Edelstein S. L. [et al.] // J. Clin. Endocrinol. Metab. – 2015. – No. 100. – Р. 1646–1653.
Indian Diabetes Prevention Programme (IDPP). The Indian Diabetes Prevention Programme shows that lifestyle modification and metformin prevent type 2 diabetes in Asian Indian subjects with impaired glucose tolerance (IDPP-1) / Ramachandran A., Snehalatha C., Mary S. [et al.] // Diabetologia. – 2006. – No. 49. – Р. 289–297.
Diabetes Prevention Program Research Group. Long-term metformin use and vitamin B12 deficiency in the Diabetes Prevention Program Outcomes Study / Aroda V. R., Edelstein S. L., Goldberg R. B. [et al.] // J. Clin. Endocrinol. Metab. – 2016. – No. 101. – Р. 1754–1761.
Cardiovascular and renal burdens of prediabetes in the USA: analysis of data from serial cross-sectional surveys, 1988–2014 / Ali M. K., Bullard K. M., Saydah S., [et al.] // Lancet Diabetes Endocrinol. – 2018. – No. 6. – Р. 392–403.
Association between prediabetes and risk of cardiovascular disease and all cause mortality: systematic review and meta-analysis / Huang Y., Cai X., Mai W., Li M, Hu Y. // BMJ. – 2016. – No. 355. – Р. i5953.
SPRINT Research Group. Effect of intensive versus standard blood pressure treatment according to baseline prediabetes status: a post hoc analysis of a randomized trial / Bress A. P., King J. B., Kreider K. E. [et al.] // Diabetes. Care. – 2017. – No. 40. – Р. 1401–1408.
Capacity of diabetes education programs to provide both diabetes self-management education and to implement diabetes prevention services / Butcher M. K., Vanderwood K. K., Hall T. O., [et al.] // J. Public. Health. Manag. Pract. – 2011. – No. 17. – Р. 242–247.
